NCT00200655View on ClinicalTrials.gov

Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

November 30, 2007

Conditions
Relapsing-remitting Multiple Sclerosis
Interventions
DRUG

Pravastatin

DRUG

Placebo

Trial Locations (1)

44093

Nantes University Hospital, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT00200655 - Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis | Biotech Hunter | Biotech Hunter